FR2315944A1 - Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme - Google Patents

Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme

Info

Publication number
FR2315944A1
FR2315944A1 FR7521147A FR7521147A FR2315944A1 FR 2315944 A1 FR2315944 A1 FR 2315944A1 FR 7521147 A FR7521147 A FR 7521147A FR 7521147 A FR7521147 A FR 7521147A FR 2315944 A1 FR2315944 A1 FR 2315944A1
Authority
FR
France
Prior art keywords
immunitary
stimulants
contg
microorganisms
human mucosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7521147A
Other languages
English (en)
French (fr)
Other versions
FR2315944B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7521147A priority Critical patent/FR2315944A1/fr
Publication of FR2315944A1 publication Critical patent/FR2315944A1/fr
Application granted granted Critical
Publication of FR2315944B1 publication Critical patent/FR2315944B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7521147A 1975-07-04 1975-07-04 Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme Granted FR2315944A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7521147A FR2315944A1 (fr) 1975-07-04 1975-07-04 Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7521147A FR2315944A1 (fr) 1975-07-04 1975-07-04 Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme

Publications (2)

Publication Number Publication Date
FR2315944A1 true FR2315944A1 (fr) 1977-01-28
FR2315944B1 FR2315944B1 (OSRAM) 1978-10-06

Family

ID=9157558

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7521147A Granted FR2315944A1 (fr) 1975-07-04 1975-07-04 Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme

Country Status (1)

Country Link
FR (1) FR2315944A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426470A1 (fr) * 1978-05-26 1979-12-21 Om Lab Sa Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426470A1 (fr) * 1978-05-26 1979-12-21 Om Lab Sa Medicament immunobiotherapique contre des maladies infectieuses des voies respiratoires

Also Published As

Publication number Publication date
FR2315944B1 (OSRAM) 1978-10-06

Similar Documents

Publication Publication Date Title
GEP20001898B (en) Method and Pharmaceutical Composition for Regulating Lipid Concentration with Mam
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
AU9159098A (en) Use of erythropoietin and iron preparations for the production of pharmaceutical combination preparations for the treatment of rheumatic diseases
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
Petersen Protein therapy and nonspecific resistance
Sullivan et al. Enkephalin in peripheral neuroendocrine tumours
Pappenheimer Bayliss-Starling Memorial Lecture (1982). Induction of sleep by muramyl peptides
ES2112818T1 (es) Composicion farmaceutica que comprende lactobacillus plantarum y arginina.
CA2382887A1 (en) Immunopotentiating compositions
Engel et al. In vivo and in vitro studies on possible pathogenic mechanisms of Actinomyces viscosus
SE9704584L (sv) Framställning av konjugerad linolsyra
FR2315944A1 (fr) Preparation pharmaceutique presentant une action de stimulation immunitaire non specifique de l'organisme
IT1306201B1 (it) Composizione adatta quale integratore alimentare e per il trattamentoterapeutico di disturbi intestinali e di alterazioni della flora
JPH01242532A (ja) 抗体産生増強型免疫賦活剤
Kourounakis et al. Effect of Freund's adjuvant on the mitogenic responses of rat lymphocytes
Leers et al. Suppurative thyroiditis: an unusual case caused by Actinomyces naeslundi
JPH0680575A (ja) 経口免疫賦活剤
EP0686039B1 (en) Method of enhancing immune response to oral vaccines
RU2137498C1 (ru) Способ лечения дисбактериозов кишечника
Woodward et al. The beneficial effect of chloromycetin in brucellosis
JPH08176000A (ja) Ｃ型肝炎治療剤
Kobayashi et al. Biphasic protection against bacterial infection in mice induced by vaccination of Propionibacterium acnes
JPH0149246B2 (OSRAM)
IE853206L (en) Use of aminosulfonic acids in treatment of inflammatory¹conditions
RU2072692C1 (ru) Штамм бактерий lactobacillus helveticus, обладающий способностью снижать уровень холестерина в крови и используемый для получения препаратов и продуктов питания для профилактики и лечения гиперхолестеринемий

Legal Events

Date Code Title Description
ST Notification of lapse